Although ERα expression might play a prominent role in the development of ovarian tumors, the application of estrogen-blocking agents (such as tamoxifen) in the therapy of ovarian cancer has achieved mixed results [16,17]. The gene discussed is ESR1; the disease is ovarian carcinoma.